🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7045284

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7045313

Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccin

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7045535

Compounds useful for inhibiting paramyxovirus neuraminidase

BioCryst Pharmaceuticals, Inc. · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7045136

Methods of immunization using recombinant poxviruses having foreign DNA expressed under th

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7041443

Porcine reproductive and respiratory syndrome virus and methods of use

Regents of the University of Minnesota · Granted Tue May 09 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7037534

Inactivation of viral infections agents by chemiluminescence activated light-sensitive com

Aphios Corporation · Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7033750

Recombinant P53 adenovirus methods and compositions

The Board of Regents of the University of Texas System · Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7019135

Anti-viral pyrimidine nucleoside analogues

University College Cardiff Consultants Limited · Granted Tue Mar 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7015024

Compositions containing recombinant poxviruses having foreign DNA expressed under the cont

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7014847

Methods for preventing reovirus recognition for the treatment of cellular proliferative di

ONCOLYTICS BIOTECH INC. · Granted Tue Mar 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6998252

Recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulato

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6998117

Cancer treatment with retroviral vectors comprising wild-type p53

The Board of Regents of the University of Texas System · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6994858

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. · Granted Tue Feb 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6987096

Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6984504

Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus replicons

The United States of America as represented by the Secretary of the Army · Granted Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6977079

Avian pneumovirus vaccine

Regents of the University of Minnesota · Granted Tue Dec 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6958345

2-hydroxymethylcyclopropylidene methylpurines and -pyrimidines as antiviral agents

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6953575

Methods of treating central nervous system disorders using viral vectors

The Regents of the University of California · Granted Tue Oct 11 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6942855

Viral vectors having reduced virulence

THE ARIZONA BOARD OF REGENTS · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6933108

Methods and compositions for use in the treatment of filovirus mediated disease conditions

The Regents of the University of California · Granted Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6930176

Major neutralization site of hepatitis E virus and use of this neutralization site in meth

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 16 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6924362

Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 02 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6924095

Retrovirus isolated from mantle histiocytes in mantle cell lymphoma

The Regents of the University of California · Granted Tue Aug 02 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6923971

Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 02 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired